Alpha Thalassemia Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Alpha Thalassemia Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Alpha Thalassemia Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Alpha Thalassemia Overall Market Size
2.1 Global Alpha Thalassemia Market Size: 2021 VS 2027
2.2 Global Alpha Thalassemia Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Alpha Thalassemia Players in Global Market
3.2 Top Global Alpha Thalassemia Companies Ranked by Revenue
3.3 Global Alpha Thalassemia Revenue by Companies
3.4 Top 3 and Top 5 Alpha Thalassemia Companies in Global Market, by Revenue in 2020
3.5 Global Companies Alpha Thalassemia Product Type
3.6 Tier 1, Tier 2 and Tier 3 Alpha Thalassemia Players in Global Market
3.6.1 List of Global Tier 1 Alpha Thalassemia Companies
3.6.2 List of Global Tier 2 and Tier 3 Alpha Thalassemia Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Alpha Thalassemia Market Size Markets, 2021 & 2027
4.1.2 Iron Chelating Drugs
4.1.3 Gene Therapy
4.2 By Type - Global Alpha Thalassemia Revenue & Forecasts
4.2.1 By Type - Global Alpha Thalassemia Revenue, 2016-2021
4.2.2 By Type - Global Alpha Thalassemia Revenue, 2022-2027
4.2.3 By Type - Global Alpha Thalassemia Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Alpha Thalassemia Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Private Clinics
5.1.4 Other
5.2 By Application - Global Alpha Thalassemia Revenue & Forecasts
5.2.1 By Application - Global Alpha Thalassemia Revenue, 2016-2021
5.2.2 By Application - Global Alpha Thalassemia Revenue, 2022-2027
5.2.3 By Application - Global Alpha Thalassemia Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Alpha Thalassemia Market Size, 2021 & 2027
6.2 By Region - Global Alpha Thalassemia Revenue & Forecasts
6.2.1 By Region - Global Alpha Thalassemia Revenue, 2016-2021
6.2.2 By Region - Global Alpha Thalassemia Revenue, 2022-2027
6.2.3 By Region - Global Alpha Thalassemia Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Alpha Thalassemia Revenue, 2016-2027
6.3.2 US Alpha Thalassemia Market Size, 2016-2027
6.3.3 Canada Alpha Thalassemia Market Size, 2016-2027
6.3.4 Mexico Alpha Thalassemia Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Alpha Thalassemia Revenue, 2016-2027
6.4.2 Germany Alpha Thalassemia Market Size, 2016-2027
6.4.3 France Alpha Thalassemia Market Size, 2016-2027
6.4.4 U.K. Alpha Thalassemia Market Size, 2016-2027
6.4.5 Italy Alpha Thalassemia Market Size, 2016-2027
6.4.6 Russia Alpha Thalassemia Market Size, 2016-2027
6.4.7 Nordic Countries Alpha Thalassemia Market Size, 2016-2027
6.4.8 Benelux Alpha Thalassemia Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Alpha Thalassemia Revenue, 2016-2027
6.5.2 China Alpha Thalassemia Market Size, 2016-2027
6.5.3 Japan Alpha Thalassemia Market Size, 2016-2027
6.5.4 South Korea Alpha Thalassemia Market Size, 2016-2027
6.5.5 Southeast Asia Alpha Thalassemia Market Size, 2016-2027
6.5.6 India Alpha Thalassemia Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Alpha Thalassemia Revenue, 2016-2027
6.6.2 Brazil Alpha Thalassemia Market Size, 2016-2027
6.6.3 Argentina Alpha Thalassemia Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Alpha Thalassemia Revenue, 2016-2027
6.7.2 Turkey Alpha Thalassemia Market Size, 2016-2027
6.7.3 Israel Alpha Thalassemia Market Size, 2016-2027
6.7.4 Saudi Arabia Alpha Thalassemia Market Size, 2016-2027
6.7.5 UAE Alpha Thalassemia Market Size, 2016-2027
7 Players Profiles
7.1 Bluebird Bio
7.1.1 Bluebird Bio Corporate Summary
7.1.2 Bluebird Bio Business Overview
7.1.3 Bluebird Bio Alpha Thalassemia Major Product Offerings
7.1.4 Bluebird Bio Alpha Thalassemia Revenue in Global (2016-2021)
7.1.5 Bluebird Bio Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Alpha Thalassemia Major Product Offerings
7.2.4 Novartis Alpha Thalassemia Revenue in Global (2016-2021)
7.2.5 Novartis Key News
7.3 Kiadis Pharma
7.3.1 Kiadis Pharma Corporate Summary
7.3.2 Kiadis Pharma Business Overview
7.3.3 Kiadis Pharma Alpha Thalassemia Major Product Offerings
7.3.4 Kiadis Pharma Alpha Thalassemia Revenue in Global (2016-2021)
7.3.5 Kiadis Pharma Key News
7.4 Acceleron Pharma
7.4.1 Acceleron Pharma Corporate Summary
7.4.2 Acceleron Pharma Business Overview
7.4.3 Acceleron Pharma Alpha Thalassemia Major Product Offerings
7.4.4 Acceleron Pharma Alpha Thalassemia Revenue in Global (2016-2021)
7.4.5 Acceleron Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Alpha Thalassemia Market Opportunities & Trends in Global Market
Table 2. Alpha Thalassemia Market Drivers in Global Market
Table 3. Alpha Thalassemia Market Restraints in Global Market
Table 4. Key Players of Alpha Thalassemia in Global Market
Table 5. Top Alpha Thalassemia Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Alpha Thalassemia Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Alpha Thalassemia Revenue Share by Companies, 2016-2021
Table 8. Global Companies Alpha Thalassemia Product Type
Table 9. List of Global Tier 1 Alpha Thalassemia Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alpha Thalassemia Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Alpha Thalassemia Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Alpha Thalassemia Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Alpha Thalassemia Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Alpha Thalassemia Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Alpha Thalassemia Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Alpha Thalassemia Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Alpha Thalassemia Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Alpha Thalassemia Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Alpha Thalassemia Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Alpha Thalassemia Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Alpha Thalassemia Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Alpha Thalassemia Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Alpha Thalassemia Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Alpha Thalassemia Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Alpha Thalassemia Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Alpha Thalassemia Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Alpha Thalassemia Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Alpha Thalassemia Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Alpha Thalassemia Revenue, (US$, Mn), 2022-2027
Table 30. Bluebird Bio Corporate Summary
Table 31. Bluebird Bio Alpha Thalassemia Product Offerings
Table 32. Bluebird Bio Alpha Thalassemia Revenue (US$, Mn), (2016-2021)
Table 33. Novartis Corporate Summary
Table 34. Novartis Alpha Thalassemia Product Offerings
Table 35. Novartis Alpha Thalassemia Revenue (US$, Mn), (2016-2021)
Table 36. Kiadis Pharma Corporate Summary
Table 37. Kiadis Pharma Alpha Thalassemia Product Offerings
Table 38. Kiadis Pharma Alpha Thalassemia Revenue (US$, Mn), (2016-2021)
Table 39. Acceleron Pharma Corporate Summary
Table 40. Acceleron Pharma Alpha Thalassemia Product Offerings
Table 41. Acceleron Pharma Alpha Thalassemia Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Alpha Thalassemia Segment by Type
Figure 2. Alpha Thalassemia Segment by Application
Figure 3. Global Alpha Thalassemia Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Alpha Thalassemia Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Alpha Thalassemia Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Alpha Thalassemia Revenue in 2020
Figure 8. By Type - Global Alpha Thalassemia Revenue Market Share, 2016-2027
Figure 9. By Application - Global Alpha Thalassemia Revenue Market Share, 2016-2027
Figure 10. By Region - Global Alpha Thalassemia Revenue Market Share, 2016-2027
Figure 11. By Country - North America Alpha Thalassemia Revenue Market Share, 2016-2027
Figure 12. US Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Alpha Thalassemia Revenue Market Share, 2016-2027
Figure 16. Germany Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 17. France Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Alpha Thalassemia Revenue Market Share, 2016-2027
Figure 24. China Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 28. India Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Alpha Thalassemia Revenue Market Share, 2016-2027
Figure 30. Brazil Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Alpha Thalassemia Revenue Market Share, 2016-2027
Figure 33. Turkey Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Alpha Thalassemia Revenue, (US$, Mn), 2016-2027
Figure 37. Bluebird Bio Alpha Thalassemia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Novartis Alpha Thalassemia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Kiadis Pharma Alpha Thalassemia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Acceleron Pharma Alpha Thalassemia Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Bluebird Bio
Novartis
Kiadis Pharma
Acceleron Pharma